VA proposes changes to standards of care

The Department of Veterans Affairs (VA) announced a proposal to change access standards for community care and urgent care by allowing veterans to seek care with the VA or other community providers.

The provisions would take effect in June and allow veterans to seek community care with access standards based on, in part, average drive time and appointment wait times. Under the MISSION Act, which was signed into law in June 2018, veterans could meet eligibility criteria for community care. The standards are proposed to meet those requirements under the MISSION Act.

The proposal comes at a time when wait times for VA patients have been shown to be shorter than for those with private insurance––a result of years of improvement initiatives at VA.

For veterans seeking primary care, mental health and non-institutional extended care services, the proposal offers a 30-minute average drive time standard. For specialty care, the average drive time standard would be 60 minutes. If drive times are above those thresholds to access VA care, veterans could seek treatment from other eligible local providers.

For appointment wait-time standards, the VA proposed 20 days for primary care, mental healthcare and non-institutional extended care services. For specialty care, the standard is 28 days from the date of request with certain exceptions under the proposal.

For urgent care, veterans will have the choice to receive certain services when and where they need it––a new benefit where veterans will choose a provider in VA’s community care network with the potential of a copayment.

“Our medical services must meet our Veterans’ needs and reinforce the trust that forms the basis for every interaction with VA,” VA Secretary Robert Wilkie said in statement. “Our new access standards are a vital part of this effort. … With VA’s new access standards, the future of the VA health care system will lie in the hands of Veterans––exactly where it should be.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.